PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 135 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $634,000 | +174.5% | 18,524 | +42.3% | 0.02% | +325.0% |
| Q3 2021 | $231,000 | -85.1% | 13,015 | -62.4% | 0.00% | -85.7% |
| Q2 2021 | $1,554,000 | +26.0% | 34,620 | -27.3% | 0.03% | +33.3% |
| Q1 2021 | $1,233,000 | +48.0% | 47,620 | +15.3% | 0.02% | +40.0% |
| Q4 2020 | $833,000 | +3.0% | 41,301 | -0.2% | 0.02% | -37.5% |
| Q3 2020 | $809,000 | +129.2% | 41,400 | +107.0% | 0.02% | +41.2% |
| Q2 2020 | $353,000 | – | 20,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |